Back to Treatments

Treatment

Tenofovir disoproxil fumarate (TDF)

1
Conditions
3
Trials
500
Participants
60%
Average Safety

Condition Evidence

Acute hepatitis B

3 trials · 500 participants

80% effectiveness · 60% safety
Tenofovir disoproxil fumarate (TDF) | DFDA